Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Repurposing an epithelial sodium channel inhibitor as a therapy for murine and human skin inflammation.
Journal: Science translational medicine
Published: December 11, 2024
Musculoskeletal ultrasound characteristics of checkpoint inhibitor-associated inflammatory arthritis.
Journal: Seminars in arthritis and rheumatism
Published: May 07, 2024
Immune Responses in Checkpoint Myocarditis Across Heart, Blood, and Tumor.
Journal: bioRxiv : the preprint server for biology
Published: October 04, 2023
Immune responses in checkpoint myocarditis across heart, blood and tumour.
Journal: Nature
Published: April 20, 2023
Single-cell transcriptomic analyses reveal distinct immune cell contributions to epithelial barrier dysfunction in checkpoint inhibitor colitis.
Journal: Nature medicine
Published: June 06, 2022
Effect of a multidisciplinary Severe Immunotherapy Complications Service on outcomes for patients receiving immune checkpoint inhibitor therapy for cancer.
Journal: Journal for immunotherapy of cancer
Published: July 13, 2021
Predictors of Rheumatic Immune-Related Adverse Events and De Novo Inflammatory Arthritis After Immune Checkpoint Inhibitor Treatment for Cancer.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: May 08, 2021
Temporal Trends and Outcomes Among Patients Admitted for Immune-Related Adverse Events: A Single-Center Retrospective Cohort Study from 2011 to 2018.
Journal: The oncologist
Published: October 01, 2020
Using electronic visits (E-visits) to achieve goal serum urate levels in patients with gout in a rheumatology practice: A pilot study.
Journal: Seminars in arthritis and rheumatism
Published: December 06, 2019
Musculoskeletal rheumatic complications of immune checkpoint inhibitor therapy: A single center experience.
Journal: Seminars in arthritis and rheumatism
Published: July 11, 2018
Targeting the CBM complex causes Treg cells to prime tumours for immune checkpoint therapy.
Journal: Nature
Published: December 15, 2017
Reanalysis of the Rituximab in ANCA-Associated Vasculitis trial identifies granulocyte subsets as a novel early marker of successful treatment.
Journal: Arthritis research & therapy
Published: January 24, 2015
Showing 1-12 of 12
Last Updated: 09/26/2026